Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha M (ITGAM), also known as CD11b or Mac-1 alpha subunit, forms a heterodimer with integrin beta 2 (CD18) to create the functional receptor αMβ2 or Mac-1/CR3. This receptor is expressed on leukocytes and plays a crucial role in immune responses by mediating cell adhesion, migration, phagocytosis, and complement activation. It binds to ligands such as iC3b, fibrinogen, Factor X, and ICAM-1. Genetic variants in ITGAM are associated with autoimmune diseases like systemic lupus erythematosus. It's commonly used as a marker for myeloid lineage cells in immunohistochemistry.
Modulation of integrin-mediated cell adhesion and signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin subunit alpha M (ITGAM).